| Description | Melogliptin, also known as EMD-675992 and GRC-8200, is a potent and selective a dipeptidyl peptidase IV (DPP-IV) inhibitor potentially for treatment of type II diabetes. Melogliptin significantly reduced HbA1c from baseline as compared to placebo with a mean average reduction of 0.75 percent in patients receiving 50mg twice daily dose and 0.60 percent in patients receiving 100 mg once daily dose. |
| molecular weight | 320.37 |
| Molecular formula | C15H21FN6O |
| CAS | 868771-57-7 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |